Jump to content

Eltoprazine

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Vanished 45kd09la13 (talk | contribs) at 03:30, 15 October 2009. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Eltoprazine
Clinical data
ATC code
  • none
Identifiers
  • 1-(2,3-dihydro-1,4-benzodioxin-8-yl)piperazine
CAS Number
PubChem CID
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC12H16N2O2
Molar mass220.121 g/mol g·mol−1
3D model (JSmol)
  • C1CN(CCN1)C2=C3C(=CC=C2)OCCO3

Eltoprazine (DU-28,853) is a phenylpiperazine and so-called serenic, or antiaggressive drug, used as a research chemical in scientific studies.[1] It is closely related to several other piperazines, including fluprazine, batoprazine, DU 28412, flesinoxan, and TFMPP, as well as more distantly to the azapirones such as buspirone. Eltoprazine acts as an agonist at the 5-HT1A and 5-HT1B receptors, and as an antagonist at the 5-HT2C receptor.[2] Its serenic properties may actually be mediated by anxiogenesis.[3]

References

  1. ^ Olivier B, Mos J, Rasmussen D. (1990). "Behavioural pharmacology of the serenic, eltoprazine". Drug Metabol Drug Interact. 8 (1–2): 31–83. PMID 2091890.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  2. ^ Schipper J, Tulp MT, Sijbesma H. (1990). "Neurochemical profile of eltoprazine". Drug Metabol Drug Interact. 8 (1–2): 85–114. PMID 1982626.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  3. ^ Rodgers RJ, Cole JC, Cobain MR, Daly P, Doran PJ, Eells JR, Wallis P. (1992). "Anxiogenic-like effects of fluprazine and eltoprazine in the mouse elevated plus-maze: profile comparisons with 8-OH-DPAT, CGS 12066B, TFMPP and mCPP". Behav Pharmacol. 3 (6): 621–634. PMID 11224163.{{cite journal}}: CS1 maint: multiple names: authors list (link)